Assessment of the potential role of tryptophan as the precursor of serotonin and melatonin for the aged sleep-wake cycle and immune function: Streptopelia risoria as a model

International Journal of Tryptophan Research

Volumn 2, Issue 1, 2009, Pages 23-36

  Paredes, Sergio D ^a   Barriga, Carmen ^a   Reiter, Russel J ^b   Rodríguez, Ana B ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Immune function; Melatonin; Ringdove; Serotonin; Sleep wake cycle; Tryptophan

Indexed keywords

EID: 69549135960     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/ijtr.s1129     Document Type: Review

References (178)

1. Steinberg LA, O'Connell NC, Hatch TF, et al. Tryptophan intake influences infants' sleep latency. J Nutr. 1992;122:1781-91.
2. Jansman AJM, Kemp GWP, van Cauwenberghe S. Effect of the level of branch chain amino acids (BCAA) and tryptophan in the diet of performance of piglets. In: Book of Abstracts of the 51st EAAP congress, The Hague, The Nethelands. 2000. p. 396.
3. Gómez G, Llorca R. Aminoácidos. Biopsicología. 2000;3:548-76.
4. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology 6th ed. New York: Oxford University Press: 1991.
5. Reiter RJ, Richardson BA, Johnson LY, et al. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science. 1980;210:1372-3.
6. Reiter RJ, Craft CM, Johnson JE Jr, et al. Age-associated reduction in nocturnal melatonin levels in female rats. Endocrinology. 1981;109:1295-7.
7. Paredes SD, Terrón MP, Cubero J, et al. Comparative study of the activity/rest rhythms in young and old ringdove (Streptopelia risoria): correlation with serum levels of melatonin and serotonin. Chronobiol Int. 2006;23:779-93.
8. Ruzsas C, Mess B. Melatonin and aging. A brief survey. Neuro Endocrinol Lett. 2000;21:17-23.
9. Pietraszek MH, Urano T, Serizawa S, et al. Circadian rhythm of serotonin: influence of age. Thromb Res. 1990;60:253-7.
10. Garau C, Aparicio S, Rial RV, et al. Age-related changes in circadian rhythm of serotonin synthesis in ring doves: effects of increased tryptophan ingestion. Exp Gerontol. 2006a;41:40-8.
11. Zhdanova IV. Melatonin as a hypnotic: pro. Sleep Med Rev. 2005;9:51-65.
12. Wurtman RJ. Age-related decreases in melatonin secretion-clinical consequences. J Clin Endocrinol Metab. 2000;85:2135-6.
13. Karasek M, Reiter RJ. Melatonin and aging. Neuro Endocrinol Lett. 2002;23 Suppl:14-16.
14. Paredes SD, Barriga C, Rodríguez AB. Melatonin and tryptophan as therapeutic agents against the impairment of the sleep-wake cycle and immunosenescence due to aging in Streptopelia risoria. Neuro Endocrinol Lett. 2007a;28:757-60.
15. Sánchez S, Paredes SD, Martín MI, et al. Effect of tryptophan administration on circulating levels of melatonin and phagocytic activity. J Appl Biomed. 2004;2:169-177.
16. Paredes SD, Terrón MP, Cubero J, et al. Tryptophan increases nocturnal rest and affects melatonin and serotonin serum levels in old ringdove. Physiol Behav. 2007b;90:576-82.
17. Paredes SD, Terrón MP, Marchena AM, et al. Tryptophan modulates cell viability, phagocytosis and oxidative metabolism in old ringdoves. Basic Clin Pharmacol Toxicol. 2007c;101:56-62.
18. Mateos SS, Sánchez CL, Paredes SD, et al. Circadian levels of serotonina in plasma and brain after oral administration of tryptophan in rats. Basic Clin Pharmacol Toxicol. 2009;104:52-59.
19. Wyatt RJ, Engelman K, Kupfer DJ, et al. Effects of L-tryptophan (a natural sedative) on human sleep. Lancet. 1970;2:842-846.
20. Spinweber CL. L-tryptophan administered to chronic sleep-onset insomniacs: late-appearing reduction of sleep latency. Psychopharmacology (Berl). 1986;90:151-5.
21. Demisch K, Bauer J, Georgi K. Treatment of severe chronic insomnia with L-tryptophan and varying sleeping times. Pharmacopsychiatry. 1987;20:245-8.
22. Cubero J, Narciso D, Aparicio S, et al. Improved circadian sleep-wake cycle in infants fed a day/night dissociated formula milk. Neuro Endocrinol Lett. 2006a;27:373-80.
23. Cubero J, Narciso D, Terrón P, et al. Chrononutrition applied to formula milks to consolidate infants' sleep/wake cycle. Neuro Endocrinol Lett. 2007;28:360-6.
24. Brodie BB, Pletscher A, Shore PA. Evidence that serotonin has a role in brain function. Science. 1955;122:968.
25. Jouvet M, Vimont P, Delorme F. [Elective suppression of paradoxal sleep in the cat by monoamine oxidase inhibitors]. C R Seances Soc Biol Fil. 1965;159:1595-9.
26. Dahlstroem A, Fuxe K. Evidence for the existence of monoaminecontaining neurons in the central nervous system I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl. 1964;232:1-55.
27. Jouvet M. Biogenic amines and the states of sleep. Science. 1969;163:32-41.
28. Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther. 1966;154:499-516.
29. Koella WP. Serotonin and sleep. Exp Med Surg. 1969;27:157-68.
30. Jouvet M. Sleep and serotonin: an unfinished story. Neuropsychopharmacology. 1999;21:24S-7S.
31. Huether G, Poeggeler B, Adler L, et al. Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats. Eur J Pharmacol. 1993;283:249-54.
32. Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand. 1987;221:155-8.
33. Brismar K, Hylander B, Eliasson K, et al. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand. 1988;223:525-30.
34. Van Den Heuvel CJ, Reid KJ, Dawson D. Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. Physiol Behav. 1997;61:795-802.
35. Hartter S, Wang X, Weigmann H, et al. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J Clin Psychopharmacol. 2001;21:167-74.
36. Lavie P. Ultrashort sleep-waking schedule. III. 'Gates' and 'forbidden zones' for sleep. Electroencephalogr Clin Neurophysiol. 1986;63:414-25.
37. Buysse DJ, Nofzinger EA, Germain A, et al. Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings. Sleep. 2004;27:1245-54.
38. Long MA, Jutras MJ, Connors BW, et al. Electrical synapses coordinate activity in the suprachiasmatic nucleus. Nat Neurosci. 2005;8:61-6.
39. Dijk DJ, Cajochen C. Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. J Biol Rhythms. 1997;12:627-35.
40. Tzischinsky O, Shlitner A, Lavie P. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J Biol Rhythms. 1993;8:199-209.
41. Shochat T, Luboshitzky R, Lavie P. Nocturnal melatonin onset is phase locked to the primary sleep gate. Am J Physiol. 1997;273:R364-70.
42. Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms. 1997;12:657-65.
43. Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron. 1997;19:91-102.
44. Hunt AE, Al-Ghoul WM, Gillette MU, et al. Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol. 2001;280:C110-8.
45. Golombek DA, Pevet P, Cardinali DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev. 1996;20:403-12.
46. Tenn CC, Niles LP. The antidopaminergic action of S-20098 is mediated by benzodiazepine/GABA(A) receptors in the striatum. Brain Res. 1997;756:293-6.
47. Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology (Berl). 1990;100:222-6.
48. Grad BR, Rozencwaig R. The role of melatonin and serotonin in aging: update. Psychoneuroendocrinology. 1993;14:283-95.
49. Nave R, Peled R, Lavie P. Melatonin improves evening napping. Eur J Pharmacol. 1995;275:213-6.
50. Hughes RJ, Badia P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep. 1997;20: 124-31.
51. Satomura T, Sakamoto T, Shirakawa S, et al. Hypnotic action of melatonin during daytime administration and its comparison with triazolam. Psychiatry Clin Neurosci. 2001;55:303-4.
52. Dollins AB, Zhdanova IV, Wurtman RJ, et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A. 1994;91:1824-8.
53. Savaskan E, Ayoub MA, Ravid R, et al. Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res. 2005;38:10-16.
54. Paredes SD, Korkmaz A, Manchester LC, et al. Phytomelatonin: A review. J Exp Bot. 2009a;Doi: 10.1093/jxb/ern284.
55. Yatham LN, Liddle PF, Shiah IS, et al. Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study. Br J Psychiatry. 2001;178:448-53.
56. Maes M, Bosmans E, De Jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853-8.
57. Song C, Lin A, Bonaccorso S, et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord. 1998;49:211-9.
58. Maes M, Lin A, Bosmans E, et al. Serotonin-immune interactions in detoxified chronic alcoholic patients without apparent liver disease: activation of the inflammatory response system and lower plasma total tryptophan. Psychiatry Res. 1998;78:151-61.
59. Uthgenannt D, Schoolmann D, Pietrowsky R, et al. Effects of sleep on the production of cytokines in humans. Psychosom Med. 1995;57:97-104.
60. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997;82:1313-6.
61. Dinges DF, Douglas SD, Zaugg L, et al. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest. 1994;93:1930-9.
62. Esteban S, Nicolaus C, Garmundi A, et al. Effect of orally administered L-tryptophan on serotonin, melatonin, and the innate immune response in the rat. Mol Cell Biochem. 2004;267:39-46.
63. Barriga C, Martín MI, Tabla R, et al. Circadian rhythm of melatonin, corticosterone and phagocytosis: effect of stress. J Pineal Res. 2001;30:180-7.
64. Barriga C, Martín MI, Ortega E, et al. Physiological concentrations of melatonin and corticosterone in stress and their relationship with phagocytic activity. J Neuroendocrinol. 2002a;14:691-5.
65. Rodríguez AB, Terrón MP, Duran J, et al. Physiological concentrations of melatonin and corticosterone affect phagocytosis and oxidative metabolism of ring dove heterophils. J Pineal Res. 2001;31:31-38.
66. Paredes SD, Sánchez S, Parvez H, et al. Altered circadian rhythms of corticosterone, melatonin, and phagocytic activity in response to stress in rats. Neuro Endocrinol Lett. 2007d;28:489-95.
67. Martins E Jr, Ferreira AC, Skorupa AL, et al. Tryptophan consumption and indoleamines production by peritoneal cavity macrophages. J Leukocyte Biol. 2004;75:1116-1121.
68. Mossner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun. 1998;12:249-71.
69. Hofstetter HH, Mossner R, Lesch KP, et al. Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE. Clin Exp Immunol. 2005;142:39-44.
70. Schuff-Werner P, Splettstosser W, Schmidt F, et al. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of human mononuclear and polymorphonuclear phagocytes. Eur J Clin Invest. 1995;25:477-84.
71. Schuff-Werner P, Splettstoesser W. Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes. Adv Exp Med Biol. 1999;467:321-5.
72. Betten A, Dahlgren C, Hermodsson S, et al. Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol. 2001;70:65-72.
73. Nannmark U, Sennerby L, Bjursten LM, et al. Inhibition of leukocyte phagocytosis by serotonin and its possible role in tumor cell destruction. Cancer Lett. 1992;62:83-6.
74. Salman-Tabcheh S, Guerin MC, Torreilles J. Potential role of the peroxidase-dependent metabolism of serotonin in lowering the polymorphonuclear leukocyte bactericidal function. Free Radic Res. 1996;24:61-8.
75. Sánchez S, Sánchez C, Paredes SD, et al. Circadian variations of serotonin in plasma and different brain regions of rats. Mol Cell Biochem. 2008;317:105-111.
76. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005;27:189-200.
77. Carrillo-Vico A, Reiter RJ, Lardone PJ, et al. The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs. 2006;7:423-31.
78. Berger J. A two-clock model of circadian timing in the immune system of mammals. Pathol Biol (Paris). 2008;56:286-91.
79. Brainard GC, Watson-Whitmeyer M, Knobler RL, et al. Neuroendocrine regulation of immune parameters. Photoperiod control of the spleen in Syrian hamsters. Ann N Y Acad Sci. 1988;540:704-6.
80. Maestroni GJ, Hertens E, Galli P, et al. Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin. J Pineal Res. 1996;21:131-9.
81. Scalabrino G, Ferioli ME, Nebuloni R, et al. Effects of pinealectomy on the circadian rhythms of the activities of polyamine biosynthetic decarboxylases and tyrosine adminotransferase in different organs of the rat. Endocrinology. 1979a;104:377-84.
82. Scalabrino G, Ferioli ME, Basagri M, et al. Endocrine regulation of thymic biosynthetic polyamine decarboxylases in adult rat. Am J Physiol. 1979b;237:E6-10.
83. Fraschini F, Ferioli ME, Nebuloni R, et al. Pineal gland and polyamines. J Neural Transm. 1980;48:209-21.
84. Jankovic BD, Knezevic Z, Kojic L, et al. Pineal gland and immune system. Immune functions in the chick embryo pinealectomized at 96 hours of incubation. Ann N Y Acad Sci. 1994;719:398-409.
85. del Gobbo V, Libri V, Villani N, et al. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int J Immunopharmacol. 1989;11:567-73.
86. Libri V, Del Gobbo V, Villani N, et al. Influence of pineal gland lesion on interleukin-2 production and natural killer activity in C57BL/6 mice. Pharmacol Res. 1990;22 Suppl 3:52.
87. Rodríguez AB, Lea RW. Effect of pinealectomy upon the nonspecific immune response of the ring-dove (Streptopelia risoria). J Pineal Res. 1994;16:159-66.
88. Yellon SM. Daily melatonin treatments regulate the circadian melatonin rhythm in the adult Djungarian hamster. J Biol Rhythms. 1996;11:4-13.
89. Haldar C, Singh R, Guchhait P. Relationship between the annual rhythms in melatonin and immune system status in the tropical palm squirrel, Funambulus pennanti. Chronobiol Int. 2001;18:61-69.
90. Moore CB, Siopes TD, Steele CT, et al. Pineal melatonin secretion, but not ocular melatonin secretion, is sufficient to maintain normal immune responses in Japanese quail (Coturnix coturnix japonica). Gen Comp Endocrinol. 2002;126:352-8.
91. Pioli C, Caroleo MC, Nistico G, et al. Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol. 1993;15:463-8.
92. Molinero P, Soutto M, Benot S, et al. Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin alpha1 and thymulin concentrations: observations in rats and humans. J Neuroimmunol. 2000;103:180-8.
93. Raghavendra V, Singh V, Kulkarni SK, et al. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem. 2001;221:57-62.
94. Liu F, Ng TB, Fung MC. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J Neural Transm. 2001;108:397-405.
95. Reiter RJ, Tan DX, Osuna C, et al. Actions of melatonin in the reduction of oxidative stress: A review. J Biomed Sci. 2000;7:444-58.
96. d'Emmanuele di Villa Bianca R, Marzocco S, Di Paola R, et al. Melatonin prevents lipopolysaccharide-induced hyporeactivity in rat. J Pineal Res. 2004;36:146-54.
97. Maestroni GJ, Conti A, Pierpaoli W. Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism. Immunology. 1988;63:465-9.
98. Ben-Nathan D, Maestroni GJ, Lustig S, et al. Protective effects of melatonin in mice infected with encephalitis viruses. Arch Virol. 1995;140:223-30.
99. Bonilla E, Valero-Fuenmayor N, Pons H, et al. Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus. Cell Mol Life Sci. 1997;53:430-34.
100. Bonilla E, Rodon C, Valero N, et al. Melatonin prolongs survival of immunodepressed mice infected with the Venezuelan equine encephalomyelitis virus. Trans R Soc Trop Med Hyg. 2001;95:207-10.
101. Bonilla E, Valero N, Chacín-Bonilla L, et al. Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus. Neurochem Res. 2003;28:681-6.
102. Timiras, P. Physiological basis of aging and geriatrics. 2nd ed. Boca Raton: CRC Press; 1994.
103. Reeves S, Bench C, Howard R. Ageing and the nigrostriatal dopaminergic system. Int J Geriatr Psychiatry. 2002;17:359-70.
104. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol. 1997;56:1269-75.
105. Mattson MP. Cellular and neurochemical aspects of aging human brain. In Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander JG, eds. Principles of geriatric medicine and gerontology. 5th ed. New York: McGraw-Hill. 1999;p 1193-1208.
106. Meltzer CC, Smith G, Price JC, et al. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res. 1998;813:167-71.
107. Maines LW, Keck BJ, Smith JE, et al. Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain. Synapse. 1999;32:58-66.
108. Ursin R. Serotonin and sleep. Sleep Med Rev. 2002;6:55-69.
109. Glass JD, DiNardo LA, Ehlen JC. Dorsal raphe nuclear stimulation of SCN serotonin and circadian phase-resetting. Brain Res. 2000;859:224-32.
110. Arendt J. Melatonin and the mammalian pineal gland. London: Chapman and Hall; 1995.
111. Karasek M. Melatonin in humans-where we are 40 years after its discovery. Neuro Endocrinol Lett. 1999;20:179-88.
112. Karasek M, Reiter RJ, Cardinali DP, et al. Future of melatonin as a therapeutic agent. Neuro Endocrinol Lett. 2002;23(Suppl 1):118-121.
113. Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev. 1995;19:553-71.
114. Rodríguez AB, Barriga C, Paredes SD, et al. Age, melatonin and the immune system. In Pandalai SG, ed. Recent Research Developments in Molecular and Cellular Biochemistry. Vol. 2, Part II. Trivandrum: Research Sign Post. 2005;p. 255-87.
115. Bergiannaki JD, Soldatos CR, Paparrigopoulos TJ, et al. Low and high melatonin excretors among healthy individuals. J Pineal Res. 1995;18:159-64.
116. Arendt J. Melatonin. Clin Endocrinol (Oxf). 1988;29:205-29.
117. Pandi-Perumal SR, Seils LK, Kayumov L, et al. Senescence, sleep, and circadian rhythms. Ageing Res Rev. 2002;1:559-604.
118. Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18:425-32.
119. Pandi-Perumal SR, Zisapel N, Srinivasan V, et al. Melatonin and sleep in aging population. Exp Gerontol. 2005;40:911-25.
120. Blanco M, Kriber N, Cardinali DP. [A survey of sleeping difficulties in an urban Latin American population]. Rev Neurol. 2004;39: 115-19.
121. Blanco M, Kriguer N, Lloret SP, et al. Attitudes towards treatment among patients suffering from sleep disorders. A Latin American survey. BMC Fam Pract. 2003;4:17.
122. Duffy JF, Czeisler CA. Age-related change in the relationship between circadian period, circadian phase, and diurnal preference in humans. Neurosci Lett. 2002;318:117-20.
123. Daan S, Beersma DG, Borbely AA. Timing of human sleep: recovery process gated by a circadian pacemaker. Am J Physiol. 1984;246: R161-83.
124. Swaab DF, Dubelaar EJ, Hofman MA, et al. Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res. 2002;138:343-73.
125. Ginaldi L, De Martinis M, D'Ostilio A, et al. The immune system in the elderly: I. Specific humoral immunity. Immunol Res. 1999a;20:101-8.
126. Rea IM, Stewart M, Campbell P, et al. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology. 1996;42:69-78.
127. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev. 1999;108:1-7.
128. McLeod JD. Apoptotic capability in ageing T cells. Mech Ageing Dev. 2000;121:151-9.
129. Richter M, Jodouin CA. The delay in the synthesis and secretion of immunoglobulins by the B cells of healthy ambulatory elderly is due to subtle defects in the null cells and the B cells. Aging Immunol Infect Dis. 1993;4:1-16.
130. Song H, Price PW, Cerny J. Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev. 1997;160:55-62.
131. McArthur WP. Effect of aging on immunocompetent and inflammatory cells. Periodontol. 2000. 1998;16:53-79.
132. Pierpaoli W, Lesnikov V. Theoretical considerations on the nature of the pineal 'ageing clock.' Gerontology. 1997;43:20-5.
133. Reiter RJ, Tan D, Kim SJ, et al. Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech Ageing Dev. 1999;110:157-73.
134. Reiter RJ. Melatonin: Lowering the high price of free radicals. News Physiol Sci. 2000a;15:246-250.
135. Reiter RJ. Melatonin and aging. In Mosley JE, Armbrecht HJ, Coe RM, Vellas B eds. The Science of Geriatrics. Vol I. New York: Springer. 2000b;p. 232-333.
136. Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and reactive nitrogen species. J Pineal Res. 2007;42:28-42.
137. Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2002;2:181-97.
138. Reiter RJ, Tan DX, Jou MJ, et al. Biogenic amines in the reduction of oxidative stress: Melatonin and its metabolites. Biogenic Amines. 2008;22:1-15.
139. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004;36:1-9.
140. Tomas-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res. 2005;39:99-104.
141. Pablos MI, Agapito MT, Guiterrez R, et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res. 1995;19:111-5.
142. Barlow-Walden LR, Reiter RJ, Abe M, et al. Melatonin stimulates glutathione peroxidase activity. Neurochem Int. 1995;26:497-502.
143. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J. 1993;1:57-60.
144. Tan D, Reiter RJ, Chen LD, et al. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis. 1994;15:215-8.
145. Rao KS, Loeb LA. DNA damage and repair in brain: relationship to aging. Mutat Res. 1992;275:317-29.
146. Strong R, Mattamal MB, Andor AC. Free radicals, the aging brain, and age-related neurodegeerative disorders. In: Yu BP, ed. Free Radicals in Aging. Boca Raton: CRC Press; 1993.
147. Acuña-Castroviejo D, Coto-Montes A, Gaia Monti M, et al. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci. 1997;60:PL23-9.
148. Mayo JC, Sainz RM, Tan DX, et al. Melatonin and Parkinson's disease. Endocrine. 2005;27:169-78.
149. van Rensburg SJ, Daniels WM, van Zyl JM, et al. A comparative study of the effects of cholesterol, beta-sitosterol, beta-sitosterol glucoside, dehydroepiandrosterone sulphate and melatonin on in vitro lipid peroxidation. Metab Brain Dis. 2000;15:257-65.
150. Ferrari CK. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology. 2004;5:275-89.
151. Bondy SC, Sharman EH. Melatonin and the aging brain. Neurochem Int. 2007;50:571-80.
152. Rodríguez AB, Marchena JM, Nogales G, et al. Correlation between the circadian rhythm of melatonin, phagocytosis, and superoxide anion levels in ring dove heterophils. J Pineal Res. 1999a;26:35-42.
153. Terron M del P, Paredes SD, Barriga C, et al. Oral administration of melatonin to old ring doves (Streptopelia risoria) increases plasma levels of melatonin and heterophil phagocytic activity. J Gerontol A Bio Sci Med Sci. 2005a;60:44-50.
154. Paredes SD, Terrón MP, Marchena AM, et al. Effect of exogenous melatonin on viability, ingestion capacity, and free-radical scavenging in heterophils from young and old ringdoves (Streptopelia risoria). Mol Cell Biochem. 2007e;304:305-14.
155. Terrón MP, Cubero J, Barriga C, et al. Phagocytosis of Candida albicans and superoxide anion Levels in ring dove (Streptopelia risoria) heterophils: effect of melatonin. J Neuroendocrinol. 2003;15:1111-5.
156. Rodríguez AB, Ortega E, Lea RW, et al. Melatonin and the phagocytic process of heterophils from the ring dove (Streptopelia risoria). Mol Cell Biochem. 1997;168:185-90.
157. Rodríguez AB, Nogales G, Ortega E, et al. Melatonin controls superoxide anion level: modulation of superoxide dismutase activity in ring dove heterophils. J Pineal Res. 1998;24:9-14.
158. Rodríguez AB, Nogales G, Marchena JM, et al. Suppression of both basal and antigen-induced lipid peroxidation in ring dove heterophils by melatonin. Biochem Pharmacol. 1999b;58:1301-6.
159. Barriga C, Marchena JM, Lea RW, et al. Effect of stress and dexamethasone treatment on circadian rhythms of melatonin and corticosterone in ring dove (Streptopelia risoria). Mol Cell Biochem. 2002b;232:27-31.
160. Paredes SD, Sánchez S, Rial RV, et al. Changes in behaviour and in the circadian rhythms of melatonin and corticosterone in rats subjected to a forced-swimming test. J Appl Biomed. 2005;3:47-56.
161. Paredes SD, Terrón MP, Valero V, et al. Orally administered melatonin improves nocturnal rest in young and old ringdoves (Streptopelia risoria). Basic Clin Pharmacol Toxicol. 2007f;100:258-68.
162. Paredes SD, Marchena AM, Bejarano I, et al. Melatonin and tryptophan affect the activity-rest rhythm, core and peripheral temperatures, and interleukin levels in the ringdove: Changes with age. J Gerontol A Biol Sci Med Sci. 2009b;Doi: 10.1093/gerona/gln054.
163. Campbell SS, Murphy PJ. Relationships between sleep and body temperature in middle-aged and older subjects. J Am Geriatr Soc. 1998;46:458-62.
164. Barriga-Ibars C, Rodríguez-Moratinos AB, Esteban S, et al. [Interrelations between sleep and the immune status]. Rev Neurol. 2005;40:548-56.
165. Terrón MP, Paredes SD, Barriga C, et al. Comparative study of the heterophil phagocytic function in young and old ring doves (Streptopelia risoria) and its relationship with melatonin levels. J Comp Physiol [B]. 2004;174:421-7.
166. Terrón MP, Cubero J, Marchena JM, et al. Melatonin and aging: in vitro effect of young and mature ring dove physiological concentrations of melatonin on the phagocytic function of heterophils from old ring dove. Exp Gerontol. 2002;37:421-6.
167. Terrón MP, Paredes SD, Barriga C, et al. Melatonin, lipid peroxidation, and age in heterophils from the ring dove (Streptopelia risoria). Free Radic Res. 2005b;39:613-9.
168. Ouichou A, Pevet P. Implication of tryptophan in the stimulatory effect of delta-sleep-inducing peptide on indole secretion from perifused rat pineal glands. Biol Signals. 1992;1:78-87.
169. Cubero J, Narciso D, Valero V, et al. The oral administration of tryptophan improves nocturnal rest in young animals: Correlation with melatonin. Biogenic Amines. 2006b;20:53-62.
170. Garau C, Aparicio S, Rial RV, et al. Age related changes in the activityrest circadian rhythms and c-fos expression of ring doves with aging. Effects of tryptophan intake. Exp Gerontol. 2006b;41:430-38.
171. Cirelli C, Tononi G. On the functional significance of c-fos induction during the sleep-waking cycle. Sleep. 2000;23:453-69.
172. Cubero J, Narciso D, Valero V, et al. Oral administration of L-tryptophan in the morning affects phagocytosis and oxidative metabolism in heterophils of Streptopelia roseogrisea. Biogenic Amines. 2005;19:209-21.
173. Maestroni GJ. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs. 2001;10:467-76.
174. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem. 2002;2:167-79.
175. Dubbels R, Reiter RJ, Klenke E, et al. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res. 1995;18:28-31.
176. Hattori A, Migitaka H, Iigo M, et al. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int. 1995;35:627-34.
177. Badria FA. Melatonin, serotonin, and tryptamine in some egyptian food and medicinal plants. J Med Food. 2002;5:153-7.
178. Paredes SD. [Effect of the administration of melatonin and tryptophan on the activity-rest rhythms, phagocytic function and oxidative metabolism in Streptopelia risoria. Modifications with age]. Cáceres: Servicio de Publicaciones de la Universidad de Extremadura; 2007.